Feixia Dong

641 total citations · 1 hit paper
8 papers, 518 citations indexed

About

Feixia Dong is a scholar working on Complementary and alternative medicine, Molecular Biology and Nephrology. According to data from OpenAlex, Feixia Dong has authored 8 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Complementary and alternative medicine, 1 paper in Molecular Biology and 1 paper in Nephrology. Recurrent topics in Feixia Dong's work include Berberine and alkaloids research (1 paper), Erythropoietin and Anemia Treatment (1 paper) and Diabetes, Cardiovascular Risks, and Lipoproteins (1 paper). Feixia Dong is often cited by papers focused on Berberine and alkaloids research (1 paper), Erythropoietin and Anemia Treatment (1 paper) and Diabetes, Cardiovascular Risks, and Lipoproteins (1 paper). Feixia Dong collaborates with scholars based in China and United States. Feixia Dong's co-authors include Jiarong Lan, Yanyun Zhao, Guoli Sun, Wenjie Zheng, HE Li-qun, Jie Du, Mark L. Entman, Jing Xu, Gang Chen and Shuhua Han and has published in prestigious journals such as Journal of the American Society of Nephrology, Journal of Ethnopharmacology and European Journal of Clinical Pharmacology.

In The Last Decade

Feixia Dong

8 papers receiving 502 citations

Hit Papers

Meta-analysis of the effect and safety of berberine in th... 2014 2026 2018 2022 2014 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feixia Dong China 6 236 173 124 84 71 8 518
Wenjie Zheng China 5 237 1.0× 190 1.1× 123 1.0× 87 1.0× 52 0.7× 6 490
Jiayin Han China 15 111 0.5× 188 1.1× 214 1.7× 53 0.6× 34 0.5× 49 744
Yanmei Lou China 15 84 0.4× 251 1.5× 195 1.6× 75 0.9× 50 0.7× 29 676
Yiyi Jin China 16 98 0.4× 353 2.0× 66 0.5× 66 0.8× 47 0.7× 31 747
Sensuke Konno United States 17 178 0.8× 338 2.0× 74 0.6× 32 0.4× 53 0.7× 71 781
Jiarong Lan China 6 231 1.0× 131 0.8× 112 0.9× 82 1.0× 53 0.7× 9 415
Tung‐Wei Hung Taiwan 18 68 0.3× 308 1.8× 53 0.4× 62 0.7× 75 1.1× 50 804
Yangyang Wang China 13 89 0.4× 218 1.3× 68 0.5× 26 0.3× 52 0.7× 40 592
Shuang Xia China 13 71 0.3× 205 1.2× 74 0.6× 50 0.6× 67 0.9× 28 557
Shuang Ren China 13 104 0.4× 364 2.1× 131 1.1× 41 0.5× 35 0.5× 32 757

Countries citing papers authored by Feixia Dong

Since Specialization
Citations

This map shows the geographic impact of Feixia Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feixia Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feixia Dong more than expected).

Fields of papers citing papers by Feixia Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feixia Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feixia Dong. The network helps show where Feixia Dong may publish in the future.

Co-authorship network of co-authors of Feixia Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Feixia Dong. A scholar is included among the top collaborators of Feixia Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feixia Dong. Feixia Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
2.
Li, Min, et al.. (2020). Effectiveness of hypoxia-induced factor prolyl hydroxylase inhibitor for managing anemia in chronic kidney disease: a systematic review and meta-analysis. European Journal of Clinical Pharmacology. 77(4). 491–507. 6 indexed citations
3.
Lan, Jiarong, et al.. (2014). Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension. Journal of Ethnopharmacology. 161. 69–81. 361 indexed citations breakdown →
4.
Dong, Feixia, Xinzhi Zhang, Feng Wu, & HE Li-qun. (2012). The effects of Kangxianling on renal fibrosis as assessed with a customized gene chip. Journal of Traditional Chinese Medicine. 32(2). 229–233. 7 indexed citations
5.
Chen, Gang, HE Li-qun, Feixia Dong, et al.. (2011). CXCL16 Recruits Bone Marrow-Derived Fibroblast Precursors in Renal Fibrosis. Journal of the American Society of Nephrology. 22(10). 1876–1886. 111 indexed citations
6.
Dong, Feixia, et al.. (2010). The clinical research on serum cystatin-C alteration on stage II chronic kidney disease with gubenquduyishen decoction treatment. Journal of Ethnopharmacology. 131(3). 581–584. 7 indexed citations
7.
Dong, Feixia & Liqun He. (2009). The Change-Over of Yin-yang and Gene Regulation in Kidney Deficiency Syndromes. Journal of Traditional Chinese Medicine. 29(3). 237–239. 1 indexed citations
8.
Dong, Feixia, et al.. (2009). The effect of traditional Chinese medicine on the proliferation of mesenchymal stem cells in vitro. International Journal of Oral and Maxillofacial Surgery. 38(5). 593–593. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026